Vycor Medical Inc (VYCO): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

33.37M
As of 2025-12-31
33.37M
As of 2026-06-30
+0.9%
3-year compound annual growth
+4.0%
5-year compound annual growth
+11.8%
10-year compound annual growth
724.49M2010-12-31: 724.49M2011-12-31: 5.38M2012-12-31: 6.02M2013-12-31: 6.64M2014-12-31: 10.78M2015-12-31: 10.93M2016-12-31: 11.34M2017-12-31: 19.82M2018-12-31: 23.14M2019-12-31: 25.29M2020-12-31: 27.43M2021-12-31: 30.82M2022-12-31: 32.53M2023-12-31: 32.63M2024-12-31: 33.37M2025-12-31: 33.37M33.37M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3133.37M0.0%2026-03-31, Balance as of period end
2024-12-3133.37M+2.3%2026-03-31, Balance as of period end
2023-12-3132.63M+0.3%2025-04-15, Balance as of period end
2022-12-3132.53M+5.5%2024-04-16, Balance as of period end
2021-12-3130.82M+12.3%2023-04-14, Balance as of period end
2020-12-3127.43M+8.5%2022-04-13, Balance as of period end
2019-12-3125.29M+9.3%2021-03-31, Balance as of period end
2018-12-3123.14M+16.7%2020-03-27, Balance as of period end
2017-12-3119.82M+74.9%2019-03-29, Balance as of period end
2016-12-3111.34M+3.7%2018-03-30, Balance as of period end
2015-12-3110.93M+1.4%2017-03-31, Balance as of period end
2014-12-3110.78M+62.4%2016-03-30, Balance as of period end
2013-12-316.64Mn/c2015-03-31, Balance as of period end
2012-12-316.02M+11.9%2014-04-07, Balance as of period end
2011-12-315.38M-99.3%2013-04-01, Balance as of period end
2010-12-31724.49Mn/a2012-03-30, Balance as of period end